Cytokinetics INC
SEC CIK 1061983 · CYTK · last insider filing 2026-06-29
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Blum Robert I | Director · President & CEO | filed 2006 - 2026 |
| Parshall B Lynne | Director | filed 2013 - 2026 |
| Kaye Edward M. MD | Director | filed 2016 - 2026 |
| Henderson John T | Director | filed 2009 - 2026 |
| Wierenga Wendell | Director | filed 2025 - 2026 |
| Wysenski Nancy | Director | filed 2020 - 2026 |
| Daly James M | Director | filed 2025 - 2026 |
| Landry Robert E | Director | filed 2025 - 2026 |
| Bhanji Muna | Director | filed 2021 - 2026 |
| Harrington Robert Arthur | Director | filed 2022 - 2026 |
| Wierenga Wendall | Director | filed 2011 - 2025 |
| Costa Santo J | Director | filed 2010 - 2024 |
| Smith Sandford D | Director | filed 2012 - 2024 |
| Califf Robert | Director | filed 2018 - 2022 |
| Gage L Patrick | Director | filed 2009 - 2021 |
| Gilbert Denise | Director | filed 2008 - 2016 |
| DOW Stephen M | Director | filed 2006 - 2013 |
| Spudich James A | Director | filed 2006 - 2011 |
| Heidrich A Grant III | Director | filed 2006 - 2011 |
| Schmertzler Michael | Director | filed 2006 - 2010 |
| Sabry James H | Director · President and CEO | filed 2006 - 2010 |
| Mcdade Mark | Director | filed 2006 - 2009 |
| Homcy Charles J | Director | filed 2006 - 2008 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Lee Sung | EVP, Chief Financial Officer | filed 2024 - 2026 |
| Malik Fady Ibraham | SVP Research & Early Dev | filed 2012 - 2026 |
| Callos Andrew | EVP, Chief Commercial Officers | filed 2021 - 2026 |
| Hessekiel Jeffrey | Chief Legal & Admin Officer | filed 2025 - 2026 |
| Wong Robert | VP, Chief Accounting Officer | filed 2019 - 2024 |
| Pletcher Brett A | EVP, Chief Legal Officer | filed 2024 - 2024 |
| Jaw Ching | SVP Finance & CFO | filed 2017 - 2023 |
| Schlossberg Mark A | SVP - Legal & General Counsel | filed 2019 - 2022 |
| Cragg David | V.P., Human Resources | filed 2006 - 2022 |
| Roddy Peter S | SVP Finance & CAO | filed 2018 - 2018 |
| Mcdowell Caryn Gordon | GC & Chief Compliance Officer | filed 2016 - 2018 |
| Morgan Bradley Paul | SVP Drug Discovery & Early Dev | filed 2015 - 2017 |
| Wolff Andrew A | SVP Clinical R&D, CMO | filed 2006 - 2017 |
| Barbari Sharon Surrey | Sr. VP, Finance & CFO | filed 2006 - 2017 |
| Charpentier Bonnie | SVP Regulatory & Compliance | filed 2014 - 2017 |
| Schnieders Elisabeth | Sr. VP, Business Development | filed 2016 - 2017 |
| Morgans David J JR | SVP-Preclinical R&D | filed 2006 - 2011 |
| Rabson Michael | SVP Business Dev/Legal & GC | filed 2008 - 2009 |
| Trautman JAY K | VP, Research | filed 2006 - 2008 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.